Uluru, Inc. (ULU) is a specialty pharmaceutical company that develops and markets a portfolio of wound-care products.The company's latest breakthrough product is Altrazeal, an FDA-approved drug that employs the company's proprietary Nanoflex Aggregate technology.
ULU Could Easily Capture Significant Market Share in an Enormous Industry!
Piribo, the online business intelligence firm for the bio-tech and pharmaceutical industry, forecasts the global wound-care market will see double digit growth – and will reach $12.5B in sales in just two years! So ULU has begun an aggressive promotional campaign to crack that market wide open!
No comments:
Post a Comment